|
modulation of excitatory postsynaptic potential
|
GO_0098815 |
[Any process that modulates the frequency, rate or extent of excitatory postsynaptic potential (EPSP). EPSP is a process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.] |
|
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction
|
GO_0014852 |
[Any process that modulates the frequency, rate or extent of skeletal muscle contraction by variation of the pattern of stimulation by nervous system.] |
|
obsolete repairosome
|
GO_0000108 |
[OBSOLETE. A stable complex of proteins that carry out the DNA damage recognition and incision reactions characteristic of nucleotide excision repair (NER), such as DNA damage recognition, DNA helix unwinding, and endonucleolytic cleavage at sites flanking damaged DNA; includes TFIIH subunits and additional polypeptides; may form in the absence of DNA damage.] |
|
GO_0000106
|
GO_0000106 |
|
|
imidazoleglycerol-phosphate synthase activity
|
GO_0000107 |
[Catalysis of the reaction: phosphoribulosylformimino-AICAR-P + L-glutamine = D-erythro-imidazole-glycerol-phosphate + aminoimidazole carboxamide ribonucleotide + L-glutamate + 2 H+.] |
|
succinate dehydrogenase activity
|
GO_0000104 |
[Catalysis of the reaction: succinate + acceptor = fumarate + reduced acceptor.] |
|
oxidoreductase activity, acting on the CH-CH group of donors
|
GO_0016627 |
[Catalysis of an oxidation-reduction (redox) reaction in which a CH-CH group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.] |
|
L-histidine biosynthetic process
|
GO_0000105 |
[The chemical reactions and pathways resulting in the formation of L-histidine, 2-amino-3-(1H-imidazol-4-yl)propanoic acid.] |
|
L-histidine metabolic process
|
GO_0006547 |
[The chemical reactions and pathways involving L-histidine, 2-amino-3-(1H-imidazol-4-yl)propanoic acid.] |
|
L-methionine secondary active transmembrane transporter activity
|
GO_0000102 |
[Enables the transfer of L-methionine from one side of a membrane to the other, up its concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction and is driven by a chemiosmotic source of energy. Secondary active transporters include symporters and antiporters.] |
|
L-methionine transmembrane transporter activity
|
GO_0015191 |
[Enables the transfer of L-methionine from one side of a membrane to the other. L-methionine is 2-amino-4-(methylthio)butanoic acid.] |
|
S-methylmethionine transmembrane transporter activity
|
GO_0000100 |
[Enables the transfer of S-methylmethionine from one side of a membrane to the other.] |
|
sulfur amino acid transport
|
GO_0000101 |
[The directed movement of amino acids containing sulfur (cystine, methionine and their derivatives) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
|
negative regulation of skeletal muscle cell proliferation
|
GO_0014859 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle cell proliferation.] |
|
positive regulation of skeletal muscle cell proliferation
|
GO_0014858 |
[Any process that activates or increases the frequency, rate or extent of skeletal muscle cell proliferation.] |
|
regulation of tonic skeletal muscle contraction
|
GO_0014746 |
[Any process that modulates the frequency, rate or extent of tonic skeletal muscle contraction.] |
|
regulation of muscle system process
|
GO_0090257 |
[Any process that modulates the frequency, rate or extent of a muscle system process, a multicellular organismal process carried out by any of the organs or tissues in a muscle system.] |
|
negative regulation of muscle hyperplasia
|
GO_0014740 |
[Any process that stops, prevents, or reduces the frequency, rate, or extent of muscle hyperplasia.] |
|
GO_0000218
|
GO_0000218 |
|
|
obsolete vacuolar hydrogen-transporting ATPase
|
GO_0000219 |
[OBSOLETE. (Was not defined before being made obsolete).] |